Back to search
FDAFDA · Food and drugs·Recall number D-0541-2023

CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx

Published May 3, 2023 · Recall initiated: April 1, 2022

Summary

FDA records drug Class II recall D-0541-2023, published May 3, 2023 and initiated April 1, 2022. Recalling firm: Wellness BioSciences; Status: Ongoing; Reported quantity: 2000 inhalers; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA

What to do

Voluntary: Firm initiated · Other

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wellness BioSciences
Distributor
Nationwide within the United States
Lot
All lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx recalled?

Yes. FDA published recall D-0541-2023 on May 3, 2023. Reported hazard: Marketed Without an Approved NDA/ANDA

What should I do if I have this product?

Voluntary: Firm initiated · Other